U K
B U S I N E S S
P A R K
home page

The information below comes from the UK Activity Report.
Click here for further details

Xenova Xenova has sold its biopharmaceuticals manufacturing facility in Canada to QSV Biologicals for £3m. 01-Sep-2004 Xenova has sold an antibodies research facility in Farnham to Bioventix for £0.8m. 07-Jan-2004 Xenova has raised £21m in a share placing to fund its drug development programme. 27-Nov-2003 Xenova has announced a £8.5m takeover bid for KS Biomedix, and expects to raise at least £9m in a share issue to fund the development of KSB's leading drug. 15-Aug-2003 Xenova is planning to cut jobs and operating costs following the suspension of trials of its lead drug. 14-May-2003 Xenova is to close some of its drug discovery operations with the loss of up to 40 Cambridge-based jobs, as part of a strategy to conserve cash and contract out all non-essential development activities. 12-Dec-2002 Xenova is to raise about £10m in a rights issue to fund further research into a range of new drugs. 11-Sep-2002 Xenova, the biotechnology company, is to shed 45 jobs in Slough and Cambridge as part of a restructuring programme aimed at saving £9m a year. 22-Jun-2001 Xenova is to acquire Cantab Pharmaceuticals, the Cambridge-based vaccines company, for £53m. 20-Feb-2001 Xenova is seeking a merger partner in order to further the development of its biotechnology-based products. 15-Aug-2000 Xenova is raising £10m in a rights issue in order to fund trials of new drugs, and plans to commercialise them through partnerships with big pharmaceutical companies. 14-Jul-2000 Xenova is to sell MetaXen, its US-based drugs software business, to Exelixis Pharmaceuticals for £0.2m. 13-Jul-1999 Xenova has raised £6.1m in a share placing in order to help it negotiate marketing deals with large pharmaceutical companies. 02-Jul-1999 Xenova has closed its MetaXen molecular design research facility in the US, with the loss of 12 jobs, as it failed to find a buyer. 09-Jun-1999 Xenova is selling Discovery, its technology subsidiary, to TerraGen Diversity of Canada for up to £5m. 01-Apr-1999 Xenova is looking to sell stakes in its Xenova Discovery and MetaXen services businesses, as part of a plan to reduce losses and focus on drug discovery. 11-Mar-1999 Xenova, the bio-pharmaceutical group, is looking for ways to raise funds in order to stem ongoing losses. 14-Aug-1998 Xenova has reached agreement with Eli Lilly to develop drugs that reduce the risk of blood clots, and will receive research funding, licence fees and milestone payments from the US company. 19-Feb-1998 Xenova is to collaborate with the Institute of Grassland Research in Aberystwyth to identify chemical compounds in plants that can be used against disease. 16-Jan-1998 Xenova Discovery is forming a joint venture with EC&G Wallac of Finland to provide R&D services to the pharmaceutical and biotechnology sectors. 12-Dec-1997 Zeneca and Xenova have reached agreement to jointly develop pharmaceuticals from natural compounds. 20-Mar-1997 Xenova has announced a new collaboration in which Bristol-Myers Squibb will fund drug research and Xenova will get royalty payments related to the success of new products. 28-Jan-1997 Xenova has raised about £23m in a stock market placing in order to fund the development of its drugs that are in trials. 12-Dec-1996 Xenova, the biotechnology company, is planning a £25m share offering next month in order to take its experimental drugs into the next development stage. 24-Sep-1996 The information above comes from the UK Activity Report Copyright UK Business Park 1995-2007